New Tests
New tests published in the previous 90 days are listed in the following table.
| Test ID | Test Name | Published |
|---|---|---|
| HRSPF | Horse Dander, IgE with Reflex to Horse Dander Component, IgE, Serum | 03/30/2023 |
| DOGPF | Dog Dander, IgE, with Reflex to Dog Dander Components, IgE, Serum | 03/30/2023 |
| CATPF | Cat Epithelium, IgE, with Reflex to Cat Epithelium Components, IgE, Serum | 03/30/2023 |
| NHEM | Hereditary Erythrocytosis Focused Gene Panel, Next-Generation Sequencing, Varies | 03/30/2023 |
| NENZ | Red Blood Cell Enzyme Disorders Gene Panel, Next-Generation Sequencing, Varies | 03/30/2023 |
| NHHA | Hereditary Hemolytic Anemia Gene Panel, Next-Generation Sequencing, Varies | 03/30/2023 |
| NMEM | Red Blood Cell Membrane Disorders Gene Panel, Next-Generation Sequencing, Varies | 03/30/2023 |
| NHEP | Hereditary Erythrocytosis Gene Panel, Next-Generation Sequencing, Varies | 03/30/2023 |
| NCDA | Congenital Dyserythropoietic Anemia Gene Panel, Next-Generation Sequencing, Varies | 03/30/2023 |
| NCYB | Recessive Congenital Methemoglobinemia, CYB5 and CYB5 Reductase Genetic Analysis, Next-Generation Sequencing, Varies | 03/30/2023 |
| CHLAP | Chlamydia IgM and IgG Panel, Immunofluorescence, Serum | 03/28/2023 |
| CHLM | Chlamydia IgM, Immunofluorescence, Serum | 03/28/2023 |
| CHLG | Chlamydia IgG, Immunofluorescence, Serum | 03/28/2023 |
| CLLMD | Chronic Lymphocytic Leukemia (CLL) Monitoring Minimal Residual Disease Detection, Flow Cytometry, Varies | 03/28/2023 |
| FMARX | THC, MS, WB/SP Rfx | 03/27/2023 |
| FHCCF | THC Confirmation, MS, SP | 03/27/2023 |
| VZIKS | Zika Virus, PCR, Molecular Detection, Serum | 03/23/2023 |
| VZIKU | Zika Virus, PCR, Molecular Detection, Random, Urine | 03/23/2023 |
| HLHGP | Primary Hemophagocytic Lymphohistiocytosis Gene Panel, Varies | 03/23/2023 |
| HPANP | Hereditary Pancreatitis Gene Panel, Varies | 03/23/2023 |
| IMMAU | Inborn Errors of Immunity with Immune Dysregulation and Autoimmunity Gene Panel, Varies | 03/23/2023 |
| SCCNP | Severe Congenital and Cyclic Neutropenia Gene Panel, Varies | 03/23/2023 |
| TELDP | Telomere Biology Disorders Gene Panel, Varies | 03/23/2023 |
| VIRID | Viral Susceptibility, Defects in Intrinsic and Innate Immunity, Gene Panel, Varies | 03/23/2023 |
| QFEVR | Q Fever Antibody Screen with Titer Reflex, Serum | 03/23/2023 |
| BTKSG | Bruton Tyrosine Kinase, BTK Full Gene Analysis, Varies | 03/23/2023 |
| CFTRN | Cystic Fibrosis Transmembrane Conductance Regulator, CFTR, Full Gene Analysis, Varies | 03/23/2023 |
| EBLPD | Epstein Barr Virus (EBV) Susceptibility and Lymphoproliferative Disorders Gene Panel, Varies | 03/23/2023 |
| GATAS | GATA-Binding Protein 2, GATA2, Full Gene Analysis, Next-Generation Sequencing, Varies | 03/23/2023 |
| HIESG | Hyper-IgE Syndrome Gene Panel, Varies | 03/23/2023 |
| ALPSG | Autoimmune Lymphoproliferative Syndrome (ALPS) Gene Panel, Varies | 03/23/2023 |
| HIBAG | Histoplasma and Blastomyces Antigen, Enzyme Immunoassay, Serum | 03/21/2023 |
| CRTFR | Creatinine, Random, Urine | 03/21/2023 |
| CRT2F | Creatinine, 24 Hour, Urine | 03/21/2023 |
| HICBL | Histoplasma/Blastomyces Panel, Spinal Fluid | 03/17/2023 |
| SBL | Blastomyces Antibody Immunodiffusion, Serum | 03/17/2023 |
| CBL | Blastomyces Antibody Immunodiffusion, Spinal Fluid | 03/17/2023 |
| MCRNA | Chlamydia trachomatis, Miscellaneous Sites, Nucleic Acid Amplification, Varies | 03/13/2023 |
| FMPP2 | Myocarditis/Pericarditis Panel | 03/13/2023 |
| FANDR | Androstenedione | 02/27/2023 |
| F17HY | 17-Hydroxyprogesterone | 02/27/2023 |
| MCTGC | Chlamydia trachomatis and Neisseria gonorrhoeae, Miscellaneous Sites, Nucleic Acid Amplification, Varies | 02/17/2023 |
| MTRNA | Trichomonas vaginalis, Nucleic Acid Amplification, Varies | 02/17/2023 |
| TVRNA | Trichomonas vaginalis, Nucleic Acid Amplification, Varies | 02/17/2023 |
| MGRNA | Neisseria gonorrhoeae, Miscellaneous Sites, Nucleic Acid Amplification, Varies | 02/17/2023 |
| CGRNA | Chlamydia trachomatis and Neisseria gonorrhoeae, Nucleic Acid Amplification, Varies | 02/17/2023 |
| GCRNA | Neisseria gonorrhoeae, Nucleic Acid Amplification, Varies | 02/17/2023 |
| VHPV | Human Papillomavirus (HPV) Vaginal Detection with Genotyping for High-Risk Types by PCR | 02/16/2023 |
| GAPCR | Streptococcus Group A, Molecular Detection, PCR, Throat | 02/14/2023 |
| MRSAP | Methicillin Resistant Staphylococcus aureus, PCR, Nasal | 02/14/2023 |
| FCXCL | CXCL9 | 02/08/2023 |
| MRDMR | Multiple Myeloma Minimal Residual Disease by Flow Cytometry, Bone Marrow | 02/07/2023 |
| MSMRD | Myeloma Stratification and Risk-Adapted Therapy with Reflex to Minimal Residual Disease, Bone Marrow | 02/07/2023 |
| ATPCO | Anal ThinPrep Cytology with Human Papillomavirus (HPV) Co-Test, Varies | 02/06/2023 |
| NCDCC | Neurochondrin Antibody, Cell-Binding Assay, Spinal Fluid | 01/31/2023 |
| AGNTS | Anti-Glial/Neuronal Nuclear Antibody-Type 1 (AGNA-1) Titer, Serum | 01/31/2023 |
| PC1TS | Purkinje Cell Cytoplasmic Antibody Type 1 (PCA-1) Titer, Serum | 01/31/2023 |
| PCTTC | Purkinje Cell Cytoplasmic Antibody, Type Tr (PCA-Tr) Titer, Spinal Fluid | 01/31/2023 |
| APHTS | Amphiphysin Antibody Titer Assay, Serum | 01/31/2023 |
| APBTS | Adaptor Protein 3 Beta2 (AP3B2) Antibody, Tissue Immunofluorescence Titer, Serum | 01/31/2023 |
| AN1TS | Antineuronal Nuclear Antibody-Type 1 (ANNA-1) Titer, Serum | 01/31/2023 |
| AN3TC | Antineuronal Nuclear Antibody Type 3 (ANNA-3) Titer, Spinal Fluid | 01/31/2023 |
| NCDTS | Neurochondrin Antibody, Tissue Immunofluorescence Titer, Serum | 01/31/2023 |
| CRMTS | Collapsin Response-Mediator Protein-5 (CRMP-5) Neuronal IgG Titer, Serum | 01/31/2023 |
| PC2TC | Purkinje Cell Cytoplasmic Antibody Type 2 (PCA-2) Titer, Spinal Fluid | 01/31/2023 |
| PCTTS | Purkinje Cell Cytoplasmic Antibody Type Tr (PCA-Tr) Titer, Serum | 01/31/2023 |
| APBCC | Adaptor Protein 3 Beta2 (AP3B2) Antibody, Cell-Binding Assay, Spinal Fluid | 01/31/2023 |
| SP5TS | Septin-5 Antibody, Tissue Immunofluorescence Titer, Serum | 01/31/2023 |
| SP5CC | Septin-5 Antibody, Cell-Binding Assay, Spinal Fluid | 01/31/2023 |
| SP7TS | Septin-7 Antibody, Tissue Immunofluorescence Titer, Serum | 01/31/2023 |
| SP7CC | Septin-7 Antibody, Cell-Binding Assay, Spinal Fluid | 01/31/2023 |
| CRMTC | Collapsin Response-Mediator Protein-5 (CRMP-5) Neuronal IgG Titer, Spinal Fluid | 01/31/2023 |
| AN2TS | Antineuronal Nuclear Antibody Type 2 (ANNA-2) Titer, Serum | 01/31/2023 |
| SP7TC | Septin-7 Antibody, Tissue Immunofluorescence Titer, Spinal Fluid | 01/31/2023 |
| SP5CS | Septin-5 Antibody, Cell Binding Assay, Serum | 01/31/2023 |
| SP5TC | Septin-5 Antibody, Tissue Immunofluorescence, Spinal Fluid | 01/31/2023 |
| SP7CS | Septin-7 Antibody, Cell-Binding Assay, Serum | 01/31/2023 |
| PC1TC | Purkinje Cell Cytoplasmic Antibody Type 1 (PCA-1) Titer, Spinal Fluid | 01/31/2023 |
| PC2TS | Purkinje Cell Cytoplasmic Antibody Type 2 (PCA-2) Titer, Serum | 01/31/2023 |
| APBCS | Adaptor Protein 3 Beta2 (AP3B2) Antibody, Cell-Binding Assay, Serum | 01/31/2023 |
| APHTC | Amphiphysin Antibody Titer Assay, Spinal Fluid | 01/31/2023 |
| NCDTC | Neurochondrin Antibody, Tissue Immunofluorescence Titer, Spinal Fluid | 01/31/2023 |
| NCDCS | Neurochondrin Antibody, Cell-Binding Assay, Serum | 01/31/2023 |
| APBTC | Adaptor Protein 3 Beta2 (AP3B2) Antibody, Tissue Immunofluorescence Titer, Spinal Fluid | 01/31/2023 |
| AN2TC | Antineuronal Nuclear Antibody Type 2 (ANNA-2) Titer, Spinal Fluid | 01/31/2023 |
| AN3TS | Antineuronal Nuclear Antibody Type 3 (ANNA-3) Titer, Serum | 01/31/2023 |
| AN1TC | Antineuronal Nuclear Antibody-Type 1 (ANNA-1) Titer, Spinal Fluid | 01/31/2023 |
| AGNTC | Anti-Glial/Neuronal Nuclear Antibody-Type 1 (AGNA-1) Titer, Spinal Fluid | 01/31/2023 |
| GFATC | Glial Fibrillary Acidic Protein Alpha Subunit Antibody, Immunofluorescence Titer Assay, Spinal Fluid | 01/31/2023 |
| GFATS | Glial Fibrillary Acidic Protein Alpha Subunit Antibody, Immunofluorescence Titer Assay, Serum | 01/31/2023 |
| ECHNG | Echinococcus Antibody, IgG, Serum | 01/26/2023 |
| TOXCG | Toxocara Antibody, IgG, Serum | 01/26/2023 |
| TRCNG | Trichinella Antibody, IgG, Serum | 01/26/2023 |
| EHOLG | Entamoeba histolytica Antibody, Serum | 01/26/2023 |
| HELIS | Helicobacter pylori Culture with Antimicrobial Susceptibilities, Varies | 01/24/2023 |
| IL6DX | Interleukin-6, Serum | 01/23/2023 |
| ST2S | ST2, Serum | 01/20/2023 |
| WNDZ | Wilson Disease, ATP7B Full Gene Sequencing with Deletion/Duplication, Varies | 01/17/2023 |
| AHLP | AudioloGene Hearing Loss Panel, Varies | 01/17/2023 |
| OAP | Ova and Parasite, Concentrate and Permanent Smear, Microscopy, Feces | 01/05/2023 |
| TTBS | Testosterone, Total and Bioavailable, Serum | 01/04/2023 |
| TTFB | Testosterone, Total, Bioavailable, and Free, Serum | 01/04/2023 |